GlassScriptPhysician profile
Michael J Messino
NPI 1699765529
$1,102.61
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2021: $172 · 2022: $468 · 2023: $99.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $205.96 | 2019 | |
| Arbor Pharmaceuticals, INC. | $205.08 | 2022 | |
| Medtronic USA, INC. | $157.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $106.92 | 2021-2022 | |
| Incyte Corporation | $99.00 | 2023 | |
| Janssen Biotech, INC. | $74.32 | 2021-2022 | |
| Pfizer INC. | $67.30 | 2021-2022 | |
| Seagen INC. | $44.61 | 2022 | |
| Tactile Systems Technology INC | $37.99 | 2022 | |
| Astellas Pharma US INC | $18.63 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.31 | 2021 | |
| Puma Biotechnology, INC. | $14.49 | 2021 | |
| Genentech USA, INC. | $14.29 | 2022 | |
| Eisai INC. | $14.22 | 2021 | |
| Merck Sharp & Dohme LLC | $13.49 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $11.92 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Messino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.